Scott Visovatti
Overview
Explore the profile of Scott Visovatti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rich L, Patel N, Hyder S, Gurm H, Moles V, Agarwal P, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(2):100589.
PMID: 39129801
Background: Balloon pulmonary angioplasty (BPA) is currently performed at select centers worldwide, with the current standard of practice being postprocedural inpatient monitoring for 24 to 72 hours. We sought to...
2.
Philip N, Yun X, Pi H, Murray S, Hill Z, Fonticella J, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Jan;
326(3):L252-L265.
PMID: 38226418
Pulmonary arterial hypertension (PAH) is a morbid disease characterized by significant lung endothelial cell (EC) dysfunction. Prior work has shown that microvascular endothelial cells (MVECs) isolated from animals with experimental...
3.
Philip N, Pi H, Gadkari M, Yun X, Huetsch J, Zhang C, et al.
Pulm Circ
. 2023 Mar;
13(1):e12205.
PMID: 36873460
In pulmonary artery hypertension (PAH), emerging evidence suggests that metabolic abnormalities may be contributing to cellular dysfunction in PAH. Metabolic abnormalities such as glycolytic shift have been observed intracellularly in...
4.
Lewis C, Sanderson R, Vasilottos N, Zheutlin A, Visovatti S
Heart Fail Clin
. 2022 Nov;
19(1):45-54.
PMID: 36435572
Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) (CTD-PAH) is a devastating condition that may progress rapidly to cause right ventricular dysfunction, resulting in significant morbidity and mortality....
5.
Young A, Moles V, Jaafar S, Visovatti S, Huang S, Vummidi D, et al.
Arthritis Rheumatol
. 2021 Mar;
73(9):1731-1737.
PMID: 33760392
Objective: Pulmonary arterial hypertension (PAH) is one of the leading causes of mortality in systemic sclerosis (SSc). This study was undertaken to assess predictive accuracies of the DETECT algorithm and...
6.
Jaafar S, Visovatti S, Young A, Huang S, Cronin P, Vummidi D, et al.
Eur Respir J
. 2019 Jun;
54(2).
PMID: 31196948
Introduction: Pulmonary arterial hypertension (PAH) is one of the leading causes of mortality in systemic sclerosis (SSc). We explored the impact of the updated haemodynamic definition of pulmonary hypertension (PH),...
7.
Young A, Vummidi D, Visovatti S, Homer K, Wilhalme H, White E, et al.
Arthritis Rheumatol
. 2019 Feb;
71(8):1339-1349.
PMID: 30762947
Objective: Systemic sclerosis (SSc) is associated with interstitial lung disease (ILD) and pulmonary hypertension (PH). This study was undertaken to determine the prevalence, characteristics, treatment, and outcomes of PH in...
8.
Cameron D, McLaughlin V, Rubenfire M, Visovatti S, Bach D
Am J Cardiol
. 2017 Jan;
119(5):790-794.
PMID: 28040189
The ability of echocardiography (echo)/Doppler to predict elevated left ventricular (LV) end-diastolic pressure (EDP) specifically among patients with pulmonary hypertension is not well defined. This was a retrospective analysis of...
9.
Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst D, et al.
Arthritis Rheum
. 2013 Sep;
65(12):3194-201.
PMID: 24022584
Objective: Pulmonary arterial hypertension (PAH) affects up to 15% of patients with connective tissue diseases (CTDs). Previous recommendations developed as part of larger efforts in PAH did not include detailed...
10.
Deano R, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin V, et al.
JAMA Intern Med
. 2013 Apr;
173(10):887-93.
PMID: 23568223
Importance: Pulmonary hypertension (PH) is a fatal disease. Although the prognosis of pulmonary arterial hypertension (PAH) has improved with targeted therapies, the outcome is dependent on early detection and an...